Abstract
In light of increasing attention towards the use of real-world evidence (RWE) in decision making in recent years, this commentary aims to reflect on the experiences gained in accessing and using RWE for comparative effectiveness research as a part of the Innovative Medicines Initiative GetReal Consortium and discuss their implications for RWE use in decision-making.
| Original language | English |
|---|---|
| Pages (from-to) | 485-490 |
| Number of pages | 6 |
| Journal | Journal of Comparative Effectiveness Research |
| Volume | 6 |
| Issue number | 6 |
| DOIs |
|
| Publication status | Published - 2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Comparative effectiveness research
- Health technology assessment
- Non-randomized trials
- Real-world evidence
Fingerprint
Dive into the research topics of 'Practical implications of using real-world evidence (RWE) in comparative effectiveness research: Learnings from IMI-GetReal'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver